HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aldo Quattrone Selected Research

Type 2a1 Axonal Charcot-Marie-Tooth Disease

1/2009A novel founder mutation in the MFN2 gene associated with variable Charcot-Marie-Tooth type 2 phenotype in two families from Southern Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aldo Quattrone Research Topics

Disease

43Parkinson Disease (Parkinson's Disease)
12/2021 - 03/2002
16Dyskinesias (Dyskinesia)
05/2016 - 12/2004
12Parkinsonian Disorders (Parkinsonism)
01/2020 - 12/2004
11Multiple Sclerosis
02/2018 - 07/2002
11Temporal Lobe Epilepsy
08/2016 - 09/2003
10Tremor (Tremors)
01/2021 - 11/2009
8Alzheimer Disease (Alzheimer's Disease)
11/2021 - 03/2004
6Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2022 - 09/2016
6Essential Tremor (Essential Tremors)
01/2018 - 03/2007
6Dementia (Dementias)
01/2018 - 10/2006
6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2012 - 04/2004
5Epilepsy (Aura)
10/2017 - 01/2005
5Cognitive Dysfunction
12/2015 - 10/2004
4Neurodegenerative Diseases (Neurodegenerative Disease)
09/2020 - 06/2011
3Infections
01/2022 - 12/2010
3Hypokinesia (Bradykinesia)
10/2019 - 06/2005
3Partial Epilepsies (Epilepsy, Partial)
10/2017 - 02/2008
3Seizures (Absence Seizure)
06/2012 - 04/2006
2Hallucinations (Hallucination)
01/2022 - 01/2009
2Disease Progression
09/2020 - 03/2006
2Nervous System Diseases (Neurological Disorders)
01/2018 - 07/2012
2Neurodegeneration with brain iron accumulation (NBIA)
10/2017 - 07/2015
2Dystonia (Limb Dystonia)
10/2017 - 01/2015
2Hyperkinesis
02/2015 - 01/2015
2Lewy Body Disease (Lewy Body Dementia)
06/2013 - 06/2011
2Encephalitis (Encephalitis, Rasmussen)
06/2013 - 02/2004
2REM Sleep Behavior Disorder
07/2012 - 05/2011
2Psychotic Disorders (Schizoaffective Disorder)
02/2012 - 07/2004
2Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
04/2011 - 12/2006
2Relapsing-Remitting Multiple Sclerosis
12/2009 - 02/2009
1Sleep Apnea Syndromes (Sleep Apnea)
10/2021
1Muscular Diseases (Myopathy)
01/2021
1Spontaneous Abortion (Miscarriage)
12/2020
1Apnea
01/2020
1Obstructive Sleep Apnea
01/2020
1Normal Pressure Hydrocephalus
01/2020
1Scurvy (Scorbutus)
11/2019
1Multiple System Atrophy
10/2019
1Type 2 Diabetes Mellitus (MODY)
09/2019
1Ataxia (Dyssynergia)
06/2019
1Fragile X Tremor Ataxia Syndrome
06/2019
1Primary Ovarian Insufficiency
06/2019
1Color Vision Defects (Color Blindness)
03/2019
1Type 4B1 Charcot-Marie-Tooth disease
01/2019
1Opportunistic Infections (Opportunistic Infection)
02/2018

Drug/Important Bio-Agent (IBA)

22Levodopa (L Dopa)FDA LinkGeneric
10/2019 - 03/2002
17Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2010
10Proteins (Proteins, Gene)FDA Link
01/2020 - 02/2004
6MicroRNAs (MicroRNA)IBA
12/2021 - 03/2013
5Pharmaceutical PreparationsIBA
02/2018 - 11/2014
4ApomorphineFDA Link
10/2019 - 03/2002
3Dopamine (Intropin)FDA LinkGeneric
10/2019 - 10/2009
3Protons (Proton)IBA
01/2019 - 10/2017
3CoffeeFDA Link
10/2017 - 10/2010
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2016 - 11/2009
3Apolipoproteins E (ApoE)IBA
08/2016 - 10/2004
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2016 - 02/2008
3Leucine (L-Leucine)FDA Link
03/2014 - 10/2011
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2013 - 02/2009
3Superoxide Dismutase-1IBA
05/2011 - 05/2006
2G-Protein-Coupled Receptor Kinase 5IBA
12/2015 - 01/2011
2SynucleinsIBA
01/2014 - 01/2011
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2014 - 05/2011
2Dopamine Receptors (Dopamine Receptor)IBA
01/2014 - 04/2005
2Phosphotransferases (Kinase)IBA
10/2013 - 10/2011
2Glucosylceramidase (Glucocerebrosidase)IBA
06/2013 - 02/2008
2IronIBA
02/2013 - 06/2011
2Dopamine Agents (Dopaminergic Agents)IBA
03/2012 - 04/2011
2Antipsychotic Agents (Antipsychotics)IBA
02/2012 - 01/2009
2alpha-SynucleinIBA
05/2011 - 08/2006
22- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
05/2011 - 03/2007
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
04/2011 - 12/2006
2Monoamine Oxidase (MAO)IBA
02/2011 - 07/2010
2Oxidoreductases (Dehydrogenase)IBA
02/2011 - 07/2010
2Nonsense Codon (Nonsense Mutation)IBA
02/2011 - 06/2006
2Biological ProductsIBA
04/2010 - 04/2004
23-Iodobenzylguanidine (Iobenguane)IBA
11/2009 - 01/2008
2Messenger RNA (mRNA)IBA
02/2009 - 04/2004
2Levetiracetam (Keppra)FDA LinkGeneric
02/2008 - 04/2006
2ApolipoproteinsIBA
10/2006 - 09/2003
1ProgranulinsIBA
01/2022
1opicaponeIBA
01/2021
1Dynactin ComplexIBA
01/2020
1VitaminsIBA
11/2019
1TransferasesIBA
10/2019
1Dopamine Agonists (Dopamine Agonist)IBA
10/2019
1polyglycineIBA
06/2019
1myotubularinIBA
01/2019
1scyllitol (scyllo-inositol)IBA
01/2019
1Monoclonal AntibodiesIBA
02/2018
1Alemtuzumab (Campath)FDA Link
02/2018

Therapy/Procedure

15Therapeutics
01/2020 - 03/2002
3Cognitive Training
08/2014 - 05/2013
2Aftercare (After-Treatment)
10/2021 - 02/2018
2Deep Brain Stimulation
01/2010 - 12/2004
1Home Nursing (Nursing, Home)
01/2022
1Wearable Electronic Devices
01/2021
1Cesarean Section (Caesarean Section)
12/2020
1Continuous Positive Airway Pressure
01/2020
1Telescopes
03/2019